diagnostics

Letters to the editor Torie Bosch

STAT readers on diagnostic tests, marijuana regulation, and pediatric oncology

First Opinion Manil Suri and Daniel Morgan

Diagnostic tests for rare conditions present a mathematical conundrum

Health Usha Lee McFarling

Pulse oximeters’ inaccuracies in darker-skinned people require urgent action, AGs tell FDA

Health Angus Chen

American Cancer Society expands lung cancer screening guidelines for cigarette smokers

First Opinion Mara Buchbinder

Liquid biopsy for cancer recurrence creates a new kind of patient-in-waiting

First Opinion Jason Bush

A better way for doctors and health plans to manage genetic tests

Biotech Matthew Herper

STAT Plus: Delfi launches its blood test to screen for lung cancer – and reveals challenges for liquid biopsies

In the Lab Andrew Joseph

2023 Nobel Prize winner: Physics award goes to trio for electron breakthroughs

Health Lizzy Lawrence

STAT Plus: FDA seeks to regulate lab-developed tests, closing the ‘Theranos loophole’

Health Helen Branswell and Rachel Cohrs Zhang

STAT Plus: Free Covid tests will be offered again to all U.S. households

Pharmalot Ed Silverman

STAT Plus: After a high-profile pressure campaign, Cepheid agrees to sell a TB test at cost

First Opinion Peter B. Bach

What a viral study criticizing cancer screening gets very, very wrong

In the Lab Angus Chen

STAT Plus: A yogurt drink instead of a colonoscopy? Study uses engineered bacteria to detect cancer

Exclusive Sarah Owermohle

National panel will explore requiring free Covid tests

First Opinion Asia Friedman

Why new guidelines recommending screening at 40 can’t end the mammography wars

Exclusive Jonathan Wosen

STAT Plus: Truvian presents data for its desktop blood-testing device in a field still in Theranos’s shadow

Health tech Brittany Trang

STAT Plus: As Alzheimer’s drugs hit the market, the race for early detection blood tests heats up

First Opinion Howard M. Fillit

We finally have new Alzheimer’s drugs. How do we decide who gets them?

Politics John Wilkerson

STAT Plus: Grail faces uphill battle to get Medicare to cover its cancer screening test

Health Abdullahi Tsanni

New DNA test aims to make cervical cancer screening more accessible in low-income countries

Health Elaine Chen

STAT Plus: Transplant patients say new Medicare guidance puts their donated organs at risk

First Opinion Miriam A. Bredella and Robert M. Wachter

Opportunistic CT: There’s gold in them there images

First Opinion Peter D. Kramer

STAT Plus: Will AI soon diagnose politicians’ mental health conditions from afar?

First Opinion Isaac S. Kohane

STAT Plus: Three ways to test medical AI for safety

First Opinion Heather Landy

Starting breast cancer screening at 40 saved my life

Health Brittany Trang

FDA issues rare comment on approval of Covid and flu home test from company that went bankrupt

First Opinion Ruth Hailu, Andrew Beam, and Ateev Mehrotra

ChatGPT-assisted diagnosis: Is the future suddenly here?

Politics Rachel Cohrs Zhang

What people on Medicare can expect once the Covid-19 public health emergency ends

Politics Jonathan Wosen

STAT Plus: Liquid-biopsy firm Grail is spending more than ever lobbying Congress